Search

Your search keyword '"Visser, Gerard H A"' showing total 687 results
Start Over Author "Visser, Gerard H A"

Refine your results

more »

more »

more »

more »

more »
687 results on '"Visser, Gerard H A"'

5. Global surgery, obstetric, and anaesthesia indicator definitions and reporting: An Utstein consensus report

Author

Davies, Justine I., Gelb, Adrian W., Gore-Booth, Julian, Martin, Janet, Mellin-Olsen, Jannicke, Åkerman, Christina, Ameh, Emmanuel A., Biccard, Bruce M., Braut, Geir Sverre, Chu, Kathryn M., Derbew, Miliard, Ersdal, Hege Langli, Guzman, Jose Miguel, Hagander, Lars, Haylock-Loor, Carolina, Holmer, Hampus, Johnson, Walter, Juran, Sabrina, Kassebaum, Nicolas J., Laerdal, Tore, Leather, Andrew J. M., Lipnick, Michael S., Ljungman, David, Makasa, Emmanuel M., Meara, John G., Newton, Mark W., Østergaard, Doris, Reynolds, Teri, Romanzi, Lauri J., Santhirapala, Vatshalan, Shrime, Mark G., Søreide, Kjetil, Steinholt, Margit, Suzuki, Emi, Varallo, John E., Visser, Gerard H. A., Watters, David, and Weiser, Thomas G.

Subjects
World health -- Management, Medical care -- Quality management, Anesthesia -- Quality management -- Standards, Obstetrics -- Quality management -- Standards, Surgery -- Quality management -- Standards, Company business management, Biological sciences
Abstract

Background Indicators to evaluate progress towards timely access to safe surgical, anaesthesia, and obstetric (SAO) care were proposed in 2015 by the Lancet Commission on Global Surgery. These aimed to capture access to surgery, surgical workforce, surgical volume, perioperative mortality rate, and catastrophic and impoverishing financial consequences of surgery. Despite being rapidly taken up by practitioners, data points from which to derive the indicators were not defined, limiting comparability across time or settings. We convened global experts to evaluate and explicitly define-for the first time-the indicators to improve comparability and support achievement of 2030 goals to improve access to safe affordable surgical and anaesthesia care globally. Methods and findings The Utstein process for developing and reporting guidelines through a consensus building process was followed. In-person discussions at a 2-day meeting were followed by an iterative process conducted by email and virtual group meetings until consensus was reached. The meeting was held between June 16 to 18, 2019; discussions continued until August 2020. Participants consisted of experts in surgery, anaesthesia, and obstetric care, data science, and health indicators from high-, middle-, and low-income countries. Considering each of the 6 indicators in turn, we refined overarching descriptions and agreed upon data points needed for construction of each indicator at current time (basic data points), and as each evolves over 2 to 5 (intermediate) and >5 year (full) time frames. We removed one of the original 6 indicators (one of 2 financial risk protection indicators was eliminated) and refined descriptions and defined data points required to construct the 5 remaining indicators: geospatial access, workforce, surgical volume, perioperative mortality, and catastrophic expenditure. A strength of the process was the number of people from global institutes and multilateral agencies involved in the collection and reporting of global health metrics; a limitation was the limited number of participants from low- or middle-income countries-who only made up 21% of the total attendees. Conclusions To track global progress towards timely access to quality SAO care, these indicators-at the basic level-should be implemented universally as soon as possible. Intermediate and full indicator sets should be achieved by all countries over time. Meanwhile, these evolutions can assist in the short term in developing national surgical plans and collecting more detailed data for research studies., Author(s): Justine I. Davies 1,2,3,*, Adrian W. Gelb 4,5, Julian Gore-Booth 4, Janet Martin 6, Jannicke Mellin-Olsen 4,7, Christina Åkerman 8,9, Emmanuel A. Ameh 10,11, Bruce M. Biccard 12,13, Geir [...]

Published
2021
Full Text
View/download PDF

9. FIGO opinion paper: Drivers and solutions to the cesarean delivery epidemic with emphasis on the increasing rates in Africa and Southeastern Europe.

Author

Visser, Gerard H. A., Ubom, Akaninyene Eseme, Neji, Khaled, Nassar, Anwar, Jacobsson, Bo, and Nicholson, Wanda

Subjects
*CESAREAN section, *DELIVERY (Obstetrics), *MIDWIVES, *CITIES & towns, *NURSE supply & demand
Abstract

Cesarean delivery rates are rapidly increasing in Southeastern Europe (to more than 60%), North Africa (with a rate as high as 72% in Egypt), and in urban areas in Southern Africa (a rate of over 50% in Lagos, Nigeria). Data on the background to these increases are scarce, but likely to include poor birthing facilities in general hospitals, convenience for the doctor, private medicine, fear of litigation, socioeconomic status, shortage of midwives and nurses, and disappearance of vaginal instrumental deliveries. Options to reverse cesarean delivery trends are discussed. In this context there is a need to be better informed about how women are being counseled regarding vaginal or cesarean delivery. The long-term consequences in subsequent pregnancies for mothers and children may well be largely ignored, while these risks are highest in LMICs where higher birth numbers are desired. FIGO has begun discussions with obstetric and gynecologic societies, healthcare bodies, and governments in several countries discussed in this article, to find ways to lower the cesarean delivery rate. The requests came from the countries themselves, which may prove beneficial in helping advance progress. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

10. 2 year neurodevelopmental and intermediate perinatal outcomes in infants with very preterm fetal growth restriction (TRUFFLE): a randomised trial

Author

Lees, Christoph C, Marlow, Neil, van Wassenaer-Leemhuis, Aleid, Arabin, Birgit, Bilardo, Caterina M, Brezinka, Christoph, Calvert, Sandra, Derks, Jan B, Diemert, Anke, Duvekot, Johannes J, Ferrazzi, Enrico, Frusca, Tiziana, Ganzevoort, Wessel, Hecher, Kurt, Martinelli, Pasquale, Ostermayer, Eva, Papageorghiou, Aris T, Schlembach, Dietmar, Schneider, K T M, Thilaganathan, Baskaran, Todros, Tullia, Valcamonico, Adriana, Visser, Gerard H A, and Wolf, Hans

Published
2015
Full Text
View/download PDF

11. From fragmented levels of care to integrated health care: Framework toward improved maternal and newborn health

Author

Barnea, Eytan R., Nicholson, Wanda, Theron, Gerhard, Ramasauskaite, Diana, Stark, Michael, Albini, S. Mark, Nassar, Anwar H., Visser, Gerard H. A., Escobar, Maria Fernanda, Kim, Yoon Ha, Pacagnella, Rodolfo, and Wright, Alison

Subjects
Rural Population, Coronavirus disease 2019 (COVID-19), Resource distribution, Midwifery, Unit (housing), 03 medical and health sciences, 0302 clinical medicine, Nursing, Pregnancy, Obstetrics and Gynaecology, Health care, Pandemic, Humans, Medicine, Infant Health, Maternal Health Services, 030212 general & internal medicine, 030219 obstetrics & reproductive medicine, Delivery of Health Care, Integrated, business.industry, Infant, Newborn, COVID-19, Obstetrics and Gynecology, General Medicine, United States, Integrated care, Black or African American, Maternal Mortality, Health Resources, Female, Level iii, business, Delivery of Health Care, Dyad
Abstract

Worldwide, health systems and care approaches vary widely due to local reality, distance to facilities, cultural norms, resources, staff availability, geography, and politics. Consequently, globally maternal-newborn dyad care and outcomes are highly variable, leading to approximately 800 maternal deaths daily with a 100-fold difference among high- and low-resource countries. Irrespective of where care is received, maternal safety and wellbeing should be preserved. Despite ongoing efforts, however, this is not the case. Large gaps exist between spending and clinical outcomes. Segmented health care, coupled with poor planning and inadequate resource distribution, results in failure to provide essential life-saving treatment. The proposed solution is a regional integrated care model from midwife to advanced level III/IV care and the newborn unit, achieved through effective coordination by site, staff, and clinicians. This model has been successfully implemented in high- to low-resource countries in the past 20 years. In the large diverse population of the United States, constructive steps have been implemented to reduce high maternal mortality in black and rural communities. The COVID-19 pandemic demonstrates the feasibility of rapid resources coordination to provide effective advanced care. The proposed integration of resources will have a major positive impact on the maternal-newborn dyad.

Published
2021
Full Text
View/download PDF

17. Maternal allopurinol administration during suspected fetal hypoxia: a novel neuroprotective intervention? A multicentre randomised placebo controlled trial

Author

Kaandorp, Joepe J, Benders, Manon J N L, Schuit, Ewoud, Rademaker, Carin M A, Oudijk, Martijn A, Porath, Martina M, Oetomo, Sidarto Bambang, Wouters, Maurice G A J, van Elburg, Ruurd M, Franssen, Maureen T M, Bos, Arie F, de Haan, Timo R, Boon, Janine, de Boer, Inge P, Rijnders, Robbert J P, Jacobs, Corrie J W F M, Scheepers, Liesbeth H C J, Gavilanes, Danilo A W, Bloemenkamp, Kitty W M, Rijken, Monique, van Meir, Claudia A, von Lindern, Jeannette S, Huisjes, Anjoke J M, Bakker, Saskia C M J E R, Mol, Ben W J, Visser, Gerard H A, Van Bel, Frank, and Derks, Jan B

Published
2015
Full Text
View/download PDF

20. Effects of Antenatal Betamethasone on Fetal Doppler Indices and Short Term Fetal Heart Rate Variation in Early Growth Restricted Fetuses

Author

Fratelli, Nicola, Prefumo, F., Wolf, H., Hecher, Kurt, Visser, Gerard H. A., Giussani, D.A., Spaanderman, M.E.A., Weisglas-Kuperus, N., Zimmermann, A., Fratelli, Nicola, Prefumo, F., Wolf, H., Hecher, Kurt, Visser, Gerard H. A., Giussani, D.A., Spaanderman, M.E.A., Weisglas-Kuperus, N., and Zimmermann, A.

Abstract

Contains fulltext : 231356.pdf (Publisher’s version ) (Closed access)

Published
2021

25. Neonatal dexamethasone treatment for chronic lung disease of prematurity alters the hypothalamus-pituitary-adrenal axis and immune system activity at school age

Author

Karemaker, Rosa, Kavelaars, Annemieke, ter Wolbeek, Maike, Tersteeg-Kamperman, Marijke, Baerts, Wim, Veen, Sylvia, Samson, Jannie F., Visser, Gerard H., van Bel, Frank, and Heijnen, Cobi J.

Subjects
Lung diseases, Obstructive -- Care and treatment, Lung diseases, Obstructive -- Demographic aspects, Lung diseases, Obstructive -- Patient outcomes, Lung diseases, Obstructive -- Research, Dexamethasone -- Dosage and administration, Dexamethasone -- Research, Hydrocortisone -- Dosage and administration, Hydrocortisone -- Research, Immune response -- Demographic aspects, Immune response -- Research, Hypothalamic-pituitary-adrenal axis -- Physiological aspects, Hypothalamic-pituitary-adrenal axis -- Research, Infants (Premature) -- Care and treatment, Infants (Premature) -- Research, Infants (Newborn) -- Diseases, Infants (Newborn) -- Care and treatment, Infants (Newborn) -- Patient outcomes, Infants (Newborn) -- Research
Published
2008

26. Comparative analysis of 2-year outcomes in GRIT and TRUFFLE trials

Author

Ganzevoort, W., Thornton, J. G., Marlow, N., Thilaganathan, B., Arabin, B., Prefumo, F., Lees, C., Wolf, H., Van Bulck, B, Kalakoutis, G M, Sak, P, Schneider, K T M, Karpathios, S E, Major, T, Todros, T, Arduini, D, Flumini, C, Tenore, A C, Roncaglia, N, Frusca, T, Ferretti, G, Weinans, M J N, Roosmalen, J, Slikke, J W, Geijn, H, Pernet, P J M, Wolf, H, Stigter, R H, Wilczynski, J, Vasco, E, Abdullah, M, Novak‐Antolic, Z, Danielian, P, Jenkinson, S D, Welch, C R, Griffin, C, Gee, H, Tuffnell, D, Cresswell, J, Tariq, T, Sengupta, B, Tydeman, G, Churchill, D, Bewley, S, Fusi, L, Lindow, S W, Johal, W, Fairlie, F M, Neales, K, Mason, G, Scudamore, I, Konje, J, Walkinshaw, S A, Griffiths, M, Dawson, A, Mires, G, Johanson, R, Fraser, R B, Ibbs, P Hendy, Steel, S A, Ramsay, M, Robins, J B, Heard, M J, Tonge, H M, Manyonda, I T, Walker, J, Maresh, M, Yoong, A, Soothill, P, Cameron, H, Byrne, D, Beattie, B, Bober, S, Van Damme, M, Kyriakides, S, Pokorna, P, Zimmerman, A, Tsitsikas, H, Mani, E, Bosisio, P, Mastritta, E, Nicocia, M, Fabris, C, Eken, P, De Vries, L, Kubicka, Z, Ramalho, R, Rashid, M, Cerar‐Kornhauser, L, Thomas, S, Elliman, A, Sim, T, Swaminathan, S, Walker, L, McCormick, D, Sibanda, Z, Hughes, J, Kilding, J, O'Hara, A, Harpin, V, Porter, N, Pandey, S, Murtagh, K, Burton, K, MacGregor, R, Stewart, B, Klenke, H, Hallam, P, Kai, N, Graham, M, Harrison, A, Saharia, E, McGhee, T, Rowsell, P, Howie, P, Parmar, Max, Field, D, Grant, A, Steer, P, Breart, G, Levene, M, Torgeson, D, Kitzinger, S, Marlowe, N, Wolke, Dieter, Johnson, A, Arabin, Birgit, Bilardo, Caterina M, Brezinka, Christoph, Cornette, Jerome M J, Derks, Jan B, Diemert, Anke, Duvekot, Johannes J, Ferrazzi, Enrico, Fratelli, Nicola, Frusca, Tiziana, Ganzevoort, Wessel, Hecher, Kurt, Leemhuis, Aleid, Lees, Christoph C, Lobmaier, Silvia, Marlow, Neil, Martinelli, Pasquale, Maso, Gianpaolo, Missfelder‐Lobos, Hannah, Napolitano, Raffaele, Ostermayer, Eva, Papageorghiou, Aris T, Prefumo, Federico, Schlembach, Dietmar, Thilaganathan, Baskaran, Todros, Tullia, Valcamonico, Adriana, Visser, Gerard H A, Wolf, Hans, Kingdom, John, Marsal, Karel, Thornton, Jim, Valensise, Herbert, Athena Institute, APH - Global Health, APH - Quality of Care, Obstetrics and gynaecology, Papageorghiou, AT, Obstetrics and Gynaecology, AR&D - Amsterdam Reproduction & Development, and APH - Digital Health

Subjects
short‐term variation, Technology, FLOW, INFANTS, cardiotocography, ductus venosus, fetal growth restriction, monitoring, short-term variation, Umbilical Arteries, Cohort Studies, 0302 clinical medicine, Obstetrics and gynaecology, Pregnancy, GROWTH RESTRICTION, Cardiotocography, 030212 general & internal medicine, Randomized Controlled Trials as Topic, Fetal Growth Retardation, 030219 obstetrics & reproductive medicine, Radiological and Ultrasound Technology, medicine.diagnostic_test, Obstetrics, Radiology, Nuclear Medicine & Medical Imaging, short term variation, Pregnancy Outcome, Obstetrics & Gynecology, Obstetrics and Gynecology, Gestational age, General Medicine, Original Papers, TRUFFLE Study Group, Settore MED/40, Pulsatile Flow, Gestation, Female, Life Sciences & Biomedicine, INTERVENTION, Blood Flow Velocity, Ductus venosus, Cohort study, medicine.medical_specialty, Birth weight, FETAL HEART-RATE, Ultrasonography, Prenatal, 03 medical and health sciences, SDG 3 - Good Health and Well-being, FETUSES, medicine, Humans, Radiology, Nuclear Medicine and imaging, Obstetrics & Reproductive Medicine, Fetal Death, GRIT Study Group, Original Paper, Fetus, Science & Technology, business.industry, Infant, Newborn, Acoustics, Reproductive Medicine, 1114 Paediatrics and Reproductive Medicine, business
Abstract

Objective To explore the effect on perinatal outcome of different fetal monitoring strategies for early‐onset fetal growth restriction (FGR). Methods This was a cohort analysis of individual participant data from two European multicenter trials of fetal monitoring methods for FGR: the Growth Restriction Intervention Study (GRIT) and the Trial of Umbilical and Fetal Flow in Europe (TRUFFLE). All women from GRIT (n = 238) and TRUFFLE (n = 503) who were randomized between 26 and 32 weeks' gestation were included. The women were grouped according to intervention and monitoring method: immediate delivery (GRIT) or delayed delivery with monitoring by conventional cardiotocography (CTG) (GRIT), computerized CTG (cCTG) only (GRIT and TRUFFLE) or cCTG and ductus venosus (DV) Doppler (TRUFFLE). The primary outcome was survival without neurodevelopmental impairment at 2 years of age. Results Gestational age at delivery and birth weight were similar in both studies. Fetal death rate was similar between the GRIT and TRUFFLE groups, but neonatal and late death were more frequent in GRIT (18% vs 6%; P, This article's abstract has been translated into Spanish and Chinese. Follow the links from the http://onlinelibrary.wiley.com/doi/10.1002/uog.20354/abstract to view the translations. This article has been selected for Journal Club. Click https://www.isuog.org/resource/uog-journal-club-January-2020.html to view slides and discussion points.

Published
2020
Full Text
View/download PDF

28. Reference curves for the normal fetal small bowel and colon diameters; their usefulness in fetuses with suspected dilated bowel

Author

MS Verloskunde, Other research (not in main researchprogram), Lap, Chiara C M M, Voskuilen, Charlotte S, Pistorius, Lourens R, Mulder, Eduard J H, Visser, Gerard H A, Manten, Gwendolyn T R, MS Verloskunde, Other research (not in main researchprogram), Lap, Chiara C M M, Voskuilen, Charlotte S, Pistorius, Lourens R, Mulder, Eduard J H, Visser, Gerard H A, and Manten, Gwendolyn T R

Published
2020

31. FIGO/ICM guidelines for preventing Rhesus disease: A call to action.

Author

Visser, Gerard H. A., Thommesen, Trude, Di Renzo, Gian Carlo, Nassar, Anwar H., Spitalnik, Steven L., Nassar, Anwar, Visser, Gerard H. A, Barnea, Eytan, Escobar, Maria Fernanda, Kim, Yoon Ha, Nicholson, Wanda Kay, Pacagnella, R., Ramasaukaite, Diana, Theron, Gerhard, and Wright, Alison

Subjects
*GUIDELINES, *DISEASE eradication, *INTERNATIONAL organization, *MIDWIVES, *DISEASES, *ANTI-NMDA receptor encephalitis
Abstract

The introduction of anti‐Rh(D) immunoglobulin more than 50 years ago has resulted in only a 50% decrease in Rhesus disease globally owing to a low uptake of this prophylactic approach. The International Federation of Gynecology and Obstetrics, International Confederation of Midwives, and Worldwide Initiative for Rhesus Disease Eradication have reviewed current evidence regarding the utility of anti‐Rh(D) immunoglobulin. Taking into account the effectiveness anti‐Rh(D), the new guidelines propose adjusting the dose for different indications and prioritizing its administration by indication. These FIGO/ICM guidelines review the evidence regarding the usefulness of anti‐Rh(D) immunoglobulin, prioritizing its administration by indication. [ABSTRACT FROM AUTHOR]

Published
2021
Full Text
View/download PDF

37. Perinatal Outcome of Monoamniotic Twin Pregnancies

Author

Hack, Karien E., Derks, Jan B., Schaap, Arty H., Lopriore, Enrico, Elias, Sjoerd G., Arabin, Birgit, Eggink, Alex J., Sollie, Krystyna M., Mol, Ben Willem J., Duvekot, Hans J., Willekes, Christine, Go, Attie T., Koopman-Esseboom, Corine, Vandenbussche, Frank P., and Visser, Gerard H.

Published
2009
Full Text
View/download PDF

44. Delphi consensus statement on intrapartum fetal monitoring in low-resource settings

Author

Housseine, Natasha, Punt, Marieke C, Browne, Joyce L, van 't Hooft, Janneke, Maaløe, Nanna, Meguid, Tarek, Theron, Gerhard B, Franx, Arie, Grobbee, Diederick E, Visser, Gerard H A, Rijken, Marcus J, Housseine, Natasha, Punt, Marieke C, Browne, Joyce L, van 't Hooft, Janneke, Maaløe, Nanna, Meguid, Tarek, Theron, Gerhard B, Franx, Arie, Grobbee, Diederick E, Visser, Gerard H A, and Rijken, Marcus J

Published
2019

45. Significant reduction in umbilical artery metabolic acidosis after implementation of intrapartum ST waveform analysis of the fetal electrocardiogram

Author

Landman, Anadeijda J E M C, Immink-Duijker, Saskia T, Mulder, Eduard J H, Koster, Maria P H, Xodo, Serena, Visser, Gerard H A, Groenendaal, Floris, Kwee, Anneke, Landman, Anadeijda J E M C, Immink-Duijker, Saskia T, Mulder, Eduard J H, Koster, Maria P H, Xodo, Serena, Visser, Gerard H A, Groenendaal, Floris, and Kwee, Anneke

Published
2019

46. Delphi consensus statement on intrapartum fetal monitoring in low-resource settings

Author

MS Verloskunde, Poli Van Creveldkliniek Medisch, Global Health, JC onderzoeksprogramma Cardiovasculaire Epidemiologie, Circulatory Health, Brain, Child Health, Cardiovasculaire Epi Team 9, Housseine, Natasha, Punt, Marieke C, Browne, Joyce L, van 't Hooft, Janneke, Maaløe, Nanna, Meguid, Tarek, Theron, Gerhard B, Franx, Arie, Grobbee, Diederick E, Visser, Gerard H A, Rijken, Marcus J, MS Verloskunde, Poli Van Creveldkliniek Medisch, Global Health, JC onderzoeksprogramma Cardiovasculaire Epidemiologie, Circulatory Health, Brain, Child Health, Cardiovasculaire Epi Team 9, Housseine, Natasha, Punt, Marieke C, Browne, Joyce L, van 't Hooft, Janneke, Maaløe, Nanna, Meguid, Tarek, Theron, Gerhard B, Franx, Arie, Grobbee, Diederick E, Visser, Gerard H A, and Rijken, Marcus J

Published
2019

47. Significant reduction in umbilical artery metabolic acidosis after implementation of intrapartum ST waveform analysis of the fetal electrocardiogram

Author

Klinisch Verloskundigen, MS Verloskunde, Other research (not in main researchprogram), Metabole ziekten patientenzorg, MS Neonatologie, Brain, Child Health, Regenerative Medicine and Stem Cells, Landman, Anadeijda J E M C, Immink-Duijker, Saskia T, Mulder, Eduard J H, Koster, Maria P H, Xodo, Serena, Visser, Gerard H A, Groenendaal, Floris, Kwee, Anneke, Klinisch Verloskundigen, MS Verloskunde, Other research (not in main researchprogram), Metabole ziekten patientenzorg, MS Neonatologie, Brain, Child Health, Regenerative Medicine and Stem Cells, Landman, Anadeijda J E M C, Immink-Duijker, Saskia T, Mulder, Eduard J H, Koster, Maria P H, Xodo, Serena, Visser, Gerard H A, Groenendaal, Floris, and Kwee, Anneke

Published
2019

Catalog

Books, media, physical & digital resources
See catalog results